Melatonin, a natural programmed cell death inducer in cancer

Current Medicinal Chemistry

Volumn 19, Issue 22, 2012, Pages 3805-3821

  Sanchez Hidalgo M ^a,b   Guerrero, J M ^c   Villegas, I ^a   Packham, G ^b   De La Lastra, C A ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Apoptosis; Cancer cells; Cancer therapy; Caspase activation; Cell cycle; Cell death; Extrinsic apoptotic pathway; Intrinsic apoptotic pathway; Melatonin; Tumor

Indexed keywords

1 (3 ALLYL 4 OXO 2 THIAZOLIDINYLIDENE) 4 METHYLTHIOSEMICARBAZONE; CYCLOPHOSPHAMIDE; ETOPOSIDE; MELATONIN; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

AGING; APOPTOSIS; ARTICLE; BLADDER CANCER; BREAST CANCER; BREAST CARCINOMA; CANCER CELL; CANCER PREVENTION; CELL DEATH; COLON CANCER; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LUNG CANCER; LUNG CARCINOMA; MEDICAL LITERATURE; MEDICAL RESEARCH; NEOPLASM; NONHUMAN; PROLACTINOMA; PROSTATE CANCER; QUALITY OF LIFE; REPRODUCTION; SEXUAL MATURATION;

AGING; ANTIOXIDANTS; APOPTOSIS; CIRCADIAN RHYTHM; DRUG EVALUATION, PRECLINICAL; HUMANS; IMMUNE SYSTEM; MELATONIN; NEOPLASMS;

EID: 84865217143     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712801661013     Document Type: Article

References (203)

1. Reiter, R.J. Melatonin the chemical expression of darkness. Mol. Cell Endocrinol., 1991, 79(1-3), 153-158
2. Tan, D.X.; Reiter, R.J.; Manchester, L.C.; Yan, M.T.; El-Sawi, M.; Sainz, R.M.; Mayo, J.C.; Kohen, R.; Allegra, M.; Hardeland, R. Chemical and physical properties and potential mechanisms, melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Top. Med. Chem., 2002, 2(2), 181-197
3. Axelrod, J. The pineal gland, a neurochemical transducer. Science., 1974, 184(4144), 1341-1348
4. Klein, D.C.; Namboodiri, M.A.; Auerbach, D.A. The melatonin rhythm generating system, developmental aspects. Life Sci., 1981, 28(18), 1975-1986 (Pubitemid 11081289)
5. Axelrod, J.; Weissbach, H. Enzymatic O-methylation of N-acetylserotonin to melatonin. Science., 1960, 131(3409), 1312
6. Sugden, D. Melatonin biosynthesis in the mammalian pineal gland. Experientia., 1989, 45(10), 922-932 (Pubitemid 19254804)
7. Reiter, R.J.; Richardson, B.A.; Johnson L.Y.; Ferguson, B.N.; Dinh, D.T. Pineal melatonin rhythm, reduction in aging Syrian hamsters. Science., 1980, 210(4476), 1372-1373 (Pubitemid 11175499)
8. Reiter, R.J.; Craft C.M.; Johnson, J.E.; Jr. King, T.S.; Richardson, B.A.; Vaughan, G.M; Vaughan, M.K. Age-associated reduction in nocturnal pineal melatonin levels in female rats. Endocrinology., 1981, 109(4), 1295-1297 (Pubitemid 11008322)
9. Reiter, R.J. Photoperiod, its importance as an impeller of pineal and seasonal reproductive rhythms. Int. J. Biometeorol., 1980, 24(1), 57-63 (Pubitemid 10044397)
10. Touitou, Y.; Fevre-Montange, M.; Proust, J.; Klinger, E.; Nakache, J.P. Ageand sex-associated modification of plasma melatonin concentrations in man. Relationship to pathology, malignant or not, and autopsy findings. Acta Endocrinol. (Copenh)., 1985, 108(1), 135-144 (Pubitemid 15199362)
11. Venegas, C.; Garcia, J.A.; Escames, G.; Ortiz, F.; López, A.; Doerrier, C.; García-Corzo, L.; López, L.C.; Reiter, R.J.; Acuña-Castroviejo, D. Extrapineal melatonin, analysis of its subcellular distribution and fluctations. J. Pineal Res., 2012, in press
12. Hardeland, R. Melatonin, hormone of darkness and more, occurrence, control mechanisms, actions and bioactive metabolites. Cell Mol. Life Sci., 2008, 65(13), 2001-2018
13. Sanchez-Hidalgo, M.; de la Lastra, C.A.; Carrascosa-Salmoral, M.P.; Naranjo, M.C.; Gomez-Corvera, A.; Caballero, B.; Guerrero, J.M. Agerelated changes in melatonin synthesis in rat extrapineal tissues. Exp. Gerontol., 2009, 44(5), 328-334
14. Tan, D.X.; Manchester, L.C.; Hardeland, R.; Lopez-Burillo, S.; Mayo, J.C.; Sainz, R.M.; Reiter, R.J. Melatonin, a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J. Pineal Res., 2003, 34(1), 75-78
15. Claustrat, B.; Brun, J.; Chazot, G. The basic physiology and pathophysiology of melatonin. Sleep Med. Rev., 2005, 9(1), 11-24 (Pubitemid 40092915)
16. Tan, D.X.; Manchester, L.C.; Reiter, R.J.; Plummer, B.F.; Hardies, L.J.; Weintraub, S.T.; Vijayalaxmi, Shepherd, A.M. A novel melatonin metabolite, cyclic 3-hydroxymelatonin, a biomarker of in vivo hydroxyl radical generation. Biochem. Biophys Res. Commun., 1998, 253(3), 614-620 (Pubitemid 29039192)
17. Tan, D.X.; Manchester, L.C.; Burkhardt, S.; Sainz, R.M.; Mayo, J.C.; Kohen, R.; Shohami. E.; Huo, Y.S.; Hardeland, R.; Reiter, R.J. N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J., 2001, 15(12), 2294-2296
18. Tan, D.X.; Hardeland, R. Manchester, L.C.; Paredes, S.D.; Korkmaz, A.; Sainz, R.M.; Mayo, J.C.; Fuentes-Broto, L.; Reiter, R.J. The changing biological roles of melatonin during evolution, from an antioxidant to signals of darkness, sexual selection and fitness. Biol. Rev. Camb. Philos. Soc., 2010, 85(3), 6076-23
19. Dubbels, R.; Reiter, R.J.; Klenke, E.; Goebel, A.; Schnakenberg, E.; Ehlers, C.; Schiwara, H.W.; Schloot, W. Melatonin in edible plants identified by radioimmunoassay and by high performance liquid chromatography-mass spectrometry. J. Pineal Res., 1995, 18(1), 28-31
20. Hattori, A.; Migitaka, H.; ligo, M.; Itoh, M.; Yamamoto, K.; Ohtani-Kaneko, R.; Hara, M.; Suzuki, T.; Reiter, R.J. Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem. Mol. Biol. Int., 1995, 35(3), 627-634 (Pubitemid 26177836)
21. Pandi-Perumal, S.R.; Srinivasan, V.; Maestroni, G.J.; Cardinali, D.P.; Poeggeler, B.; Hardeland, R. Melatonin, Nature's most versatile biological signal? FEBS J., 2006, 273(13), 2813-2838
22. Reiter, R.J. The pineal and its hormones in the control of reproduction in mammals. Endocr. Rev., 1980, 1(2), 109-131
23. Reiter, R.J.; Tan, D.X.; Manchester, L.C.; Paredes, S.D.; Mayo, J.C.; Sainz, R.M. Melatonin and reproduction revisited. Biol. Reprod., 2009, 81(3), 445-456
24. Roy, D.; Angelini, N.L.; Fujieda, H.; Brown, G.M.; Belsham, D.D. Cyclical regulation of GnRH gene expression in GT1-7 GnRH-secreting neurons by melatonin. Endocrinology., 2001, 142(11), 4711-4720 (Pubitemid 33022346)
25. Brainard, G.C.; Podolin, P.L.; Leivy, S.W.; Rollag, M.D.; Cole, C.; Barker FM. Near-ultraviolet radiation suppresses pineal melatonin content. Endocrinology., 1986, 119(5), 2201-5 (Pubitemid 17171403)
26. Webb, S.M.; Puig-Domingo, M. Role of melatonin in health and disease. Clin. Endocrinol. (Oxf)., 1995, 42(3), 221-234
27. Pevet, P.; Bothorel, B.; Slotten, H.; Saboureau, M. The chronobiotic properties of melatonin. Cell. Tissue Res., 2002, 309(1), 183-191 (Pubitemid 34744040)
28. Srinivasan, V.; Singh, J.; Pandi-Perumal, S.R.; Brown, G.M.; Spence, D.W.; Cardinali, D.P. Jet lag, circadian rhythm sleep disturbances, and depression, the role of melatonin and its analogs. Adv. Ther., 2010, 27(11), 796-813
29. Garzón. C.; Guerrero, J.M.; Aramburu, O.; Guzmán, T. Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebocontrolled study. Aging Clin. Exp. Res., 2009, 21(1), 38-42
30. Roth, T.; Stubbs, C.; Walsh, JK. Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment. Sleep., 2005, 28(3), 303-7 (Pubitemid 40315565)
31. Carrillo-Vico A, Reiter, R.J.; Lardone, P.J.; Herrera, J.L.; Fernandez-Montesinos, R.; Guerrero, J.M.; Pozo, D. The modulatory role of melatonin on immune responsiveness. Curr. Opin. Investig. Drugs., 2006, 7(5), 423-431 (Pubitemid 43772981)
32. Szczepanik, M. Melatonin and its influence on immune system. J. Physiol. Pharmacol., 2007, 58(6), 115-124
33. Guerrero, J.M.; Reiter, R.J. Melatonin-immune system relationships. Curr. Top. Med. Chem., 2002, 2(2), 167-179
34. Pieri, C.; Recchioni, R.; Moroni, F.; Marcheselli, F.; Marra, M.; Marinoni, S.; Di Primio, R. Melatonin regulates the respiratory burst of human neutrophils and their depolarization. J. Pineal Res., 1998, 24(1), 43-49 (Pubitemid 28161020)
35. Silva, S.O.; Rodrigues, M.R.; Carvalho, S.R.; Catalani, L.H.; Campa, A.; Ximenes, V.F. Oxidation of melatonin and its catabolites, N1-acetyl-N2 -formyl-5-methoxykynuramine and N1-acetyl-5-methoxykynuramine, by activated leukocytes. J. Pineal Res., 2004, 37(3), 171-175 (Pubitemid 39274114)
36. Mayo, J.C.; Sainz, R.M.; Tan, D.X.; Hardeland, R.; Leon, J.; Rodriguez, C.; Reiter, R.J. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J. Neuroimmunol., 2005, 165(1-2), 139-149 (Pubitemid 40984631)
37. Sainz, R.M.; Mayo, J.C.; Uria, H.; Kotler, M.; Antolin, I.; Rodriguez, C.; Menendez-Pelaez, A. The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis in thymocytes. J. Pineal Res., 1995, 19(4), 178-188
38. Yu, H.S.; Pang, S.F.; Tang, P.L. Increase in the level of retinal melatonin and persistence of its diurnal rhythm in rats after pinealectomy. J. Endocrinol., 1981, 91(3), 477-481 (Pubitemid 12203821)
39. Maestroni, G.J.; Covacci, V.; Conti, A. Hematopoietic rescue via T-celldependent, endogenous granulocyte-macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice. Cancer Res., 1994, 54(9), 2429-2432
40. García-Mauriño, S.; Pozo, D.; Carrillo-Vico, A.; Calvo, J.R.; Guerrero, J.M. Melatonin activates Th1 lymphocytes by increasing IL-12 production. Life Sci., 1999, 65(20), 2143-50 (Pubitemid 29524863)
41. Regodon, S.; Martin-Palomino, P.; Fernandez-Montesinos, R.; Herrera, J.L. Carrascosa-Salmoral; M.P.; Piriz, S.; Vadillo, S.; Guerrero, J.M.; Pozo, D. The use of melatonin as a vaccine agent. Vaccine., 2005, 23(46-47), 5321-5327 (Pubitemid 41579301)
42. Tan, D.X.; Manchester, L.C.; Reiter, R.J.; Qi, W.B.; Zhang, M.; Weintraub, S.T.; Cabrera, J.; Sainz, R.M.; Mayo, J.C. Identification of highly elevated levels of melatonin in bone marrow, its origin and significance. Biochim. Biophys. Acta., 1999, 1472(1-2), 206-214 (Pubitemid 29486531)
43. Conti, A.; Conconi, S.; Hertens, E.; Skwarlo-Sonta, K.; Markowska, M.; Maestroni, J.M. Evidence for melatonin synthesis in mouse and human bone marrow cells. J. Pineal Res., 2000, 28(4), 193-202 (Pubitemid 30255371)
44. Pozo, D.; Delgado, M.; Fernandez-Santos, J.M.; Calvo, J.R.; Gomariz, R.P.; Martin-Lacave, I.; Ortiz, G.G.; Guerrero, J.M. Expression of the Mel1amelatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen. FASEB J., 1997, 11(6), 466-473 (Pubitemid 27259988)
45. Carrillo-Vico, A.; Calvo, J.R.; Abreu, P.; Lardone, P.J.; Garcia-Maurino, S.; Reiter, R.J.; Guerrero, J.M. Evidence of melatonin synthesis by human lymphocytes and its physiological significance, possible role as intracrine, autocrine, and/or paracrine substance. FASEB J., 2004, 18(3), 537-539
46. Naranjo, M.C.; Guerrero, J.M.; Rubio, A.; Lardone, P.J.; Carrillo-Vico, A.; Carrascosa-Salmoral, M. P.; Jiménez-Jorge, S.; Arellano, M.V.; Leal-Noval, S.R.; Leal, M.; Lissen, E.; Molinero, P. Melatonin biosynthesis in the thymus of humans and rats. Cell. Mol. Life Sci., 2007, 64(6), 781-790 (Pubitemid 46474984)
47. Carrillo-Vico, A.; Lardone, P.J.; Fernandez-Santos, J.M.; Martin-Lacave, I.; Calvo, J.R.; Karasek, M.; Guerrero, J.M. Human lymphocyte-synthesized melatonin is involved in the regulation of the interleukin-2/interleukin-2 receptor system. J. Clin. Endocrinol. Metab., 2005, 90(2), 992-1000 (Pubitemid 40279225)
48. Carrillo-Vico, A.; Guerrero, J.M.; Lardone, P.J.; Reiter, R.J. A review of the multiple actions of melatonin on the immune system. Endocrine., 2005, 27(2), 189-200 (Pubitemid 41558451)
49. Garcia-Perganeda, A.; Pozo, D.; Guerrero, J.M.; Calvo, J.R. Signal transduction for melatonin in human lymphocytes, involvement of a pertussis toxin-sensitive G protein. J. Immunol., 1997, 159(8), 774-781
50. Carrillo-Vico, A.; Garcia-Perganeda, A.; Naji, L.; Calvo, J.R.; Romero, M.P.; Guerrero, J.M.; Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system. Cell. Mol. Life Sci., 2003, 60(10), 2272-2278 (Pubitemid 37357434)
51. Radogna, F.; Diederich, M.; Ghibelli, L. Melatonin, a pleiotropic molecule regulating inflammation. Biochem. Pharmacol., 2010, 80(12), 1844-1852
52. Bonilla, E.; Valero, N.; Chacin-Bonilla, L. Medina-Leendertz S. Melatonin and viral infections. J. Pineal Res., 2004, 36(2), 73-79 (Pubitemid 38250876)
53. Cuzzocrea, S.; Reiter, R.J. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur. J. Pharmacol., 2001, 426(1-2), 1-10 (Pubitemid 32781781)
54. Escames, G.; Acuna-Castroviejo, D.; Lopez, L.C.; Tan, D.X.; Maldonado, M.D.; Sanchez-Hidalgo M.; León, J.; Reiter, R.J.Pharmacological utility of melatonin in the treatment of septic shock, experimental and clinical evidence. J. Pharm. Pharmacol., 2006, 58(9), 1153-1565
55. Gitto, E.; Karbownik, M.; Reiter, R.J.; Tan, D.X.; Cuzzocrea, S.; Chiurazzi, P.; et al. Effects of melatonin treatment in septic newborns. Pediatr. Res., 2001, 50(6), 756-760 (Pubitemid 33121647)
56. Tan, D.X.; Chen, L.D.; Poeggeler, B.; Machester, L.C.; Reiter, R.J. Melatonin a potent endogenous hydroxyl radical scavenger. Endocr. J., 1993, 1, 57-60
57. Tan, D.X.; Poeggeler, B.; Reiter, R.J.; Chen, L.D.; Chen, S.; Manchester, L.C.; Barlow-Walden, L.R. The pineal hormone melatonin inhibits DNAadduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett., 1993, 70(1-2), 65-71 (Pubitemid 23219861)
58. Bonnefont-Rousselot, D.; Collin, F. Melatonin, action as antioxidant and potential applications in human disease and aging. Toxicology., 2010, 278(1), 55-67
59. Bonnefont-Rousselot, D.; Collin, F.; Jore, D.; Gardes-Albert, M. Reaction mechanism of melatonin oxidation by reactive oxygen species in vitro. J. Pineal Res., 2011, 50(3), 328-335
60. Galano, A.; Tan, D.X.; Reiter, R.J. Melatonin as a natural ally against oxidative stress, a physicochemical examination. J. Pineal Res., 2011, 51(1), 1-16
61. Reiter, R.J.; Tan, D.X.; Terron, M.P.; Flores, L.J.; Czarnocki, Z. Melatonin and its metabolites, new findings regarding their production and their radical scavenging actions. Acta Biochim. Pol., 2007, 54(1), 1-9 (Pubitemid 46481811)
62. Reiter, R.J.; Paredes, S.D.; Manchester, L.C.; Tan, D.X. Reducing oxidative/nitrosative stress, a newly-discovered genre for melatonin. Crit. Rev. Biochem. Mol. Biol., 2009, 44(4), 175-200
63. Melchiorri, D.; Reiter R.J.; Sewerynek, E.; Hara, M.; Chen, L.; Nistico, G. Paraquat toxicity and oxidative damage. Reduction by melatonin. Biochem. Pharmacol., 1996, 51(8), 1095-1099
64. Jou, M.J.; Peng, T.I.; Yu, P.Z.; Jou, S.B.; Reiter, R.J.; Chen, J.Y.; Wu, H.Y.; Chen, C.C.; Hsu, L.F. Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J. Pineal Res., 2007, 43(4), 389-403 (Pubitemid 47512271)
65. Choi, S.I.; Dadakhujaev, S.; Ryu, H.; Im Kim, T.; Kim, E.K. Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors. J. Pineal Res., 2011, 51(1), 94-103
66. Wang, H.; Li, L.; Zhao, M.; Chen, Y.H.; Zhang, Z.H.; Zhang, C.; Ji, Y.L.; Meng, X.H.; Xu, D.X. Melatonin alleviates lipopolysaccharide-induced placental cellular stress response in mice. J. Pineal Res., 2011, 50(4), 418-426
67. Barlow-Walden, L.R.; Reiter, R.J.; Abe, M.; Pablos, M.; Menendez-Pelaez, A.; Chen, L.D.; Poeggeler, B. Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int., 1995, 26(5), 497-502
68. Pablos, M.I.; Reiter, R.J.; Ortiz, G.G.; Guerrero, J.M.; Agapito, M.T.; Chuang, J.I.; Sewerynek, E. Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light. Neurochem. Int., 1998, 32(1), 69-75 (Pubitemid 28020239)
69. Rodriguez, C.; Mayo, J.C.; Sainz, R.M.; Antolin, I.; Herrera, F.; Martin, V.; Reiter, R.J. Regulation of antioxidant enzymes, a significant role for melatonin. J. Pineal Res., 2004, 36(1), 1-9 (Pubitemid 38130283)
70. Leon, J.; Acuna-Castroviejo, D.; Escames, G.; Tan, D.X.; Reiter, R.J. Melatonin mitigates mitochondrial malfunction. J. Pineal Res., 2005, 38(1), 1-9 (Pubitemid 40139304)
71. Paradies, G.; Petrosillo, G.; Paradies, V.; Reiter, R.J.; Ruggiero, F.M. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J. Pineal Res., 2010, 48(4), 297-310
72. Lopez-Burillo, S.; Tan, D.X.; Mayo, J.C.; Sainz, R.M.; Manchester, L.C.; Reiter, R.J. Melatonin, xanthurenic acid, resveratrol, EGCG, vitamin C and alpha-lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents, a study of their individual and synergistic actions. J. Pineal Res., 2003, 34(4), 269-277 (Pubitemid 36469773)
73. Keng, J.W.; Koh, E.J.; Lee, S.M. Melatonin protects liver against ischemia and reperfusion injury through inhibition of toll-like receptor signaling pathway. J. Pineal Res., 2011, 50(4), 403-411
74. Bangha, E.; Elsner, P.; Kistler, G.S. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose response study. Arch. Dermatol. Res., 1996, 288(9), 522-526 (Pubitemid 26280701)
75. Herrera, J.; Nava, M.; Romero, F.; Rodriguez-Iturbe, B. Melatonin prevents oxidative stress resulting from iron and erythropoietin administration. Am. J. Kidney Dis., 2001, 37(4), 750-757 (Pubitemid 32268036)
76. Shamir, E.; Barak, Y.; Shalman, I.; Laudon, M.; Zisapel, N.; Tarrasch, R.; Elizur, A.; Weizman, R. Melatonin treatment for tardive dyskinesia, a double-blind, placebo-controlled, crossover study. Arch. Gen. Psychiatry., 2001, 58(11), 1049-1052 (Pubitemid 33051830)
77. Benot, S.; Goberna, R.; Reiter, R.J.; Garcia-Maurino, S.; Osuna, C.; Guerrero, J.M. Physiological levels of melatonin contribute to the antioxidant capacity of human serum. J. Pineal Res., 1999, 27(1), 59-64 (Pubitemid 29359459)
78. Benot, S.; Molinero, P.; Soutto, M.; Goberna, R.; Guerrero, J.M. Circadian variations in the rat serum total antioxidant status, correlation with melatonin levels. J. Pineal Res., 1998, 25(1), 1-4 (Pubitemid 28319909)
79. Bubenik, G.A.; Konturek, S.J. Melatonin and aging, prospects for human treatment. J. Physiol. Pharmacol., 2011, 62(1), 13-19
80. Poeggeler, B. Melatonin, aging, and age-related diseases, perspectives for prevention, intervention, and therapy. Endocrine., 2005, 27(2), 201-212
81. Reiter, R.J.; Tan, D.; Kim, SJ.; Manchester, L.C.; Qi, W.; Garcia, J.J.; Cabrera, J.C.; El-Sokkary, G.; Rouvier-Garay, V. Augmentation of indices of oxidative damage in life-long melatonin-deficient rats. Mech. Ageing Dev., 1999, 110(3), 157-173 (Pubitemid 29486734)
82. Reiter, R.J.; Tan, D.; Mayo, J.C.; Sainz, R.M.; Lopez-Burillo, S. Melatonin, longevity and health in the ageds anassessment. Free Radic. Res., 2002, 36(12), 1323-1329 (Pubitemid 35469519)
83. Reiter, R.J. Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animals. J. Neural Transm. Suppl., 1986, 21, 35-54
84. Bondarenko, L.O. The comparative evaluation of the effect of the season on the formation of a nighttime melatonin peak in young sexually mature and old rats. Fiziol Zh., 1992, 38(2), 111-114
85. Sanchez-Hidalgo, M.; Guerrero Montavez, J.M.; Carrascosa-Salmoral, M.P; Naranjo Gutierrez, M.C.; Lardone, PJ.; de la Lastra Romero C.A. Decreased MT1 and MT2 melatonin receptor expression in extrapineal tissues of the rat during physiological aging. J. Pineal Res., 2009, 46(1), 29-35
86. Cajochen, C.; Krauchi, K.; Wirz-Justice, A. Role of melatonin in the regulation of human circadian rhythms and sleep. J. Neuroendocrinol., 2003, 15(4), 432-437 (Pubitemid 36395244)
87. Uberos, J.; Augustin-Morales, M.C.; Molina Carballo, A.; Florido, J.; Narbona, E, .; Munoz-Hoyos, A. Normalization of the sleep-wake pattern and melatonin and 6-sulphatoxy-melatonin levels after a therapeutic trial with melatonin in children with severe epilepsy. J. Pineal Res., 2011, 50(2), 192-196
88. Reiter, R.J.; Tan, D.X.; Manchester, L.C.; El-Sawi, MR. Melatonin reduces oxidant damage and promotes mitochondrial respiration, implications for aging. Ann. N. Y. Acad. Sci., 2002, 959, 238-250 (Pubitemid 34457565)
89. Singhal, N.K.; Srivastava, G.; Patel, D.K.; Jain, S.K.; Singh, M.P. Melatonin or silymarin reduces maneb-and paraquat-induced Parkinson's disease phenotype in the mouse. J. Pineal Res., 2011, 50(2), 97-109
90. Dragicevic, N.; Copes, N.; O'Neal-Moffitt, G.; Jin, J.; Buzzeo, R.; Mamcarz, M.; Tan, J.; Cao, C.; Olcese, J.M.; Arendash, G.W.; Bradshaw, P.C. Melatonin treatment restores mitochondrial function in Alzheimer's mice, a mitochondrial protective role of melatonin membrane receptor signaling. J. Pineal Res., 2011, 51(1), 75-86
91. Tunon, M.J.; San Miguel, B.; Crespo, I.; Jorquera, F.; Santamaria, E.; Alvarez, M.; Prieto, J.; González-Gallego, J. Melatonin attenuates apoptotic liver damage in fulminant hepatic failure induced by the rabbit hemorrhagic disease virus. J. Pineal Res., 2011, 50(1), 38-45
92. Castillo, C.; Salazar, V.; Ariznavarreta, C.; Vara, E.; Tresguerres, J.A. Effect of melatonin administration on parameters related to oxidative damage in hepatocytes isolated from old Wistar rats. J. Pineal Res., 2005, 38(4), 240-246 (Pubitemid 41475435)
93. Kireev, R.A.; Tresguerres, A.C.; Castillo, C.; Salazar, V.; Ariznavarreta, C.; Vara, E.; Tresguerres, J.A. Effect of exogenous administration of melatonin and growth hormone on pro-antioxidant functions of the liver in aging male rats. J. Pineal Res., 2007, 42(1), 64-70 (Pubitemid 44924327)
94. Morioka, N.; Okatani, Y.; Wakatsuki, A. Melatonin protects against agerelated DNA damage in the brains of female senescence-accelerated mice. J. Pineal Res., 1999, 27(4), 202-209 (Pubitemid 29515430)
95. Okatani, Y.; Wakatsuki, A.; Reiter, R.J. Melatonin protects hepatic mitochondrial respiratory chain activity in senescence-accelerated mice. J. Pineal Res., 2002, 32(3), 143-148 (Pubitemid 34309880)
96. Rodríguez, MI.; Escames, G.; López, LC.; López, A.; García, J.A.; Ortiz, F.; Sánchez, V.; Romeu, M.; Acuña-Castroviejo, D. Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice. Exp. Gerontol., 2008, 43(8), 749-756
97. Escames, G.; Leon, J.; Macias, M.; Khaldy, H.; Acuna-Castroviejo, D. Melatonin counteracts lipopolysaccharide-induced expression and activity of mitochondrial nitric oxide synthase in rats. FASEB J., 2003, 17(8), 932-934
98. Blask, D.E.; Brainard, G.C.; Dauchy, R.T.; Hanifin, J.P.; Davidson, L.K.; Krause, J.A.; Sauer, L.A.; Rivera-Bermudez, M.A.; Dubocovich, M.L.; Jasser, S.A.; Lynch, D.T.; Rollag, M.D.; Zalatan, F. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res., 2005, 65(23), 11174-11184 (Pubitemid 41713389)
99. Reiter, R.J.; Tan, D.X.; Korkmaz, A.; Erren, T.C.; Piekarski, C.; Tamura, H.; Manchester, L.C. Light at night, chronodisruption, melatonin suppression, and cancer risk, a review. Crit. Rev. Oncog., 2007, 13(4), 303-328 (Pubitemid 351655045)
100. Blask, D.E.; Hill, S.M.; Dauchy, R.T.; Xiang, S.; Yuan, L.; Duplessis, T.; Mao, L.; Dauchy, E.; Sauer, L.A. Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J. Pineal Res., 2011, 51(3), 259-269
101. Mediavilla, M.D.; Sanchez-Barcelo, E.J.; Tan, D.X.; Manchester, L.; Reiter, R.J. Basic mechanisms involved in the anti-cancer effects of melatonin. Curr. Med. Chem., 2010, 17(36), 4462-4481
102. Gonzalez, A.; del Castillo-Vaquero, A.; Miro-Moran, A.; Tapia, J.A.; Salido, G.M. Melatonin reduces pancreatic tumor cell viability by altering mitochondrial physiology. J. Pineal Res., 2011, 50(3), 250-260
103. Jung-Hynes, B.; Schmit, T.L.; Reagan-Shaw, S.R.; Siddiqui, I.A.; Mukhtar, H.; Ahmad, N. Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model. J. Pineal Res., 2011, 50(2), 140-149
104. Lissoni, P. Is there a role for melatonin in supportive care? Support. Care Cancer, 2002, 10(2), 110-116 (Pubitemid 36056308)
105. Casado-Zapico, S.; Martin, V.; Garcia-Santos, G.; Rodriguez-Blanco, J.; Sanchez-Sanchez, A.M.; Luno, E.; Suárez, C.; García-Pedrero, J.M.; Menendez, S.T.; Antolín, I.; Rodriguez, C. Regulation of the expression of death receptors and their ligands by melatonin in haematological cancer cell lines and in leukaemia cells from patients. J. Pineal Res., 2011, 50(3), 345-355
106. Srinivasan, V.; Spence, D.W.; Pandi-Perumal, S.R.; Trakht, I.; Cardinali, D.P. Therapeutic actions of melatonin in cancer, possible mechanisms. Integr. Cancer Ther., 2008, 7(3), 189-203
107. Carlberg, C. Gene regulation by melatonin. Ann. N. Y. Acad. Sci., 2000, 917, 387-396.
108. Blask, D.E.; Sauer, L.A.; Dauchy, R.T. Melatonin as a chronobiotic/anticancer agent, cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr. Top. Med. Chem., 2002, 2(2), 113-132
109. Jung, B.; Ahmad, N. Melatonin in cancer management, progress and promise. Cancer Res., 2006, 66(20), 9789-9793 (Pubitemid 44672026)
110. Srinivasan, V.; Pandi-Perumal, S.R.; Brzezinski, A.; Bhatnagar, K.P.; Cardinali, D.P. Melatonin, immune function and cancer. Recent Pat. Endocr. Metab. Immune Drug Discov., 2011, 5(2), 109-123
111. Lissoni, P.; Rovelli, F.; Malugani, F.; Bucovec, R.; Conti, A.; Maestroni, G.J. Anti-angiogenic activity of melatonin in advanced cancer patients. Neuro Endocrinol. Lett., 2001, 22(1), 45-47 (Pubitemid 32186250)
112. Dziegiel, P.; Podhorska-Okolow, M.; Zabel, M. Melatonin, adjuvant therapy of malignant tumors. Med. Sci. Monit., 2008, 14(5), 64-70
113. Erren, T.C. Sleep duration, melatonin, and breast cancer, compliment and complement. Cancer Res., 2006, 66(7), 3954
114. Bartsch, C.; Bartsch, H.; Karasek, M. Melatonin in clinical oncology. Neuro Endocrinol. Lett., 2002, 23 Suppl 1, 30-38 (Pubitemid 34495379)
115. Green, D.R.; Kroemer, G. The pathophysiology of mitochondrial cell death. Science., 2004, 305(5684), 626-629 (Pubitemid 39006738)
116. Thorburn, A. Death receptor-induced cell killing. Cell Signal., 2004, 16(2), 139-144 (Pubitemid 37431163)
117. Nagata, S. Apoptosis by death factor. Cell., 1997, 88(3), 355-365 (Pubitemid 27131377)
118. Russo, A.; Terrasi, M.; Agnese, V.; Santini, D.; Bazan, V. Apoptosis, a relevant tool for anticancer therapy. Ann. Oncol., 2006, 17Suppl 7, vii115-123 (Pubitemid 43985192)
119. Sainz, R.M.; Mayo, J.C.; Rodriguez, C.; Tan, D.X.; Lopez-Burillo, S.; Reiter, R.J. Melatonin and cell death, differential actions on apoptosis in normal and cancer cells. Cell. Mol. Life Sci., 2003, 60(7), 1407-1426 (Pubitemid 36900523)
120. Wang, X. The antiapoptotic activity of melatonin in neurodegenerative diseases. CNS Neurosci. Ther., 2009, 15(4), 345-357
121. Mills, E.; Wu, P.; Seely, D.; Guyatt, G. Melatonin in the treatment of cancer, a systematic review of randomized controlled trials and meta-analysis. J. Pineal Res., 2005, 39(4), 360-366
122. Pawlikowski, M.; Winczyk, K.; Karasek, M. Oncostatic action of melatonin, facts and question marks. Neuro Endocrinol. Lett., 2002, 23Suppl 1, 24-29 (Pubitemid 34495378)
123. Hill, S.M.; Frasch, T.; Xiang, S.; Yuan, L.; Duplessis, T.; Mao, L. Molecular mechanisms of melatonin anticancer effects. Integr. Cancer Ther., 2009, 8(4), 337-346
124. Motilva, V.; Garcia-Maurino, S.; Talero, E.; Illanes, M. New paradigms in chronic intestinal inflammation and colon cancer, role of melatonin. J. Pineal Res., 2011, 51(1), 44-60
125. Kossoy, G.; Ben-Hur, H.; Popovich, I.; Zabezhinski, M.; Anisimov, V.; Zusman, I. Melatonin and colon carcinogenesis. IV. Effect of melatonin on proliferative activity and expression of apoptosis-related proteins in the spleen of rats exposed to 1, 2-dimethylhydrazine. Oncol. Rep., 2000, 7(6), 1401-1405
126. Winczyk, K.; Pawlikowski, M.; Karasek, M. Melatonin and RZR/ROR receptor ligand CGP 52608 induce apoptosis in the murine colonic cancer. J. Pineal Res., 2001, 31(2), 179-182 (Pubitemid 32778168)
127. Winczyk, K.; Pawlikowski, M.; Lawnicka, H.; Kunert-Radek, J.; Spadoni, G.; Tarzia G.; Karasek, M. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo. Neuro Endocrinol. Lett., 2002, 23Suppl 1, 50-54 (Pubitemid 34495382)
128. Tanaka, T.; Yasui, Y.; Tanaka, M.; Oyama, T.; Rahman, K.M. Melatonin suppresses AOM/DSS-induced large bowel oncogenesis in rats. Chem. Biol. Interact., 2009, 177(2), 128-136
129. Zupancic, D.; Jezernik, K.; Vidmar, G. Effect of melatonin on apoptosis, proliferation and differentiation of urothelial cells after cyclophosphamide treatment. J Pineal Res., 2008, 44(3), 299-306 (Pubitemid 351409348)
130. Tripathi, D.N.; Jena, G.B. Effect of melatonin on the expression of Nrf2 and NF-kappaB during cyclophosphamide-induced urinary bladder injury in rat. J Pineal Res., 2010, 48(4), 324-331
131. Cini, G.; Coronnello, M.; Mini, E.; Neri, B. Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat. Cancer Lett., 1998, 125(1-2), 51-59 (Pubitemid 28151909)
132. Dziegiel, P.; Podhorska-Okolow, M.; Surowiak, P.; Ciesielska, U.; Rabczynski, J.; Zabel, M. Influence of exogenous melatonin on doxorubicinevoked effects in myocardium and in transplantable Morris hepatoma in rats. In Vivo, 2003, 17(4), 325-328 (Pubitemid 36958126)
133. Filatova, N.A.; Kirpichnikova, K.M.; Aksenov, N.D.; Vakhromova, E.A.; Gamalei, I.A. Decrease in tumorigenic activity of murine hepatoma cells after treatment with antioxidants and melatonin. Tsitologiia, 53(5), 404-410
134. Xi, S.C.; Siu, S.W.; Fong, S.W.; Shiu, S.Y. Inhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin, association of antiproliferative action of the pineal hormone with mt1 receptor protein expression. Prostate., 2001, 46(1), 52-61 (Pubitemid 32157776)
135. Kabasakal, L.; Sener, G.; Balkan, J.; Dogru-Abbasoglu, S.; Keyer-Uysal, M.; Uysal M. Melatonin and beta-glucan alone or in combination inhibit the growth of dunning prostatic adenocarcinoma. Oncol. Res., 2011, 19(6), 259-263
136. Nowfar, S.; Teplitzky, S.R.; Melancon, K.; Kiefer, T.L.; Cheng, Q.; Dwived, P.D.; Bischoff, E.D.; Moro, K.; Anderson, M.B.; Dai, J.; Lai, L.; Yuan, L.; Hill, S.M. Tumor prevention by 9-cis-retinoic acid in the N-nitroso-Nmethylurea model of mammary carcinogenesis is potentiated by the pineal hormone melatonin. Breast Cancer Res. Treat., 2002, 72(1), 33-43 (Pubitemid 34274313)
137. Melancon, K.; Cheng, Q.; Kiefer, T.L.; Dai, J.; Lai, L.; Dong, C.; Yuan L, Collins A, Thiyagarajah A, Long S, Hill SM. Regression of NMU-induced mammary tumors with the combination of melatonin and 9-cis-retinoic acid. Cancer Lett., 2005, 227(1), 39-48 (Pubitemid 41033091)
138. el-Aziz, M.A.; Hassan, H.A.; Mohamed, M.H.; Meki, A.R.; Abdel-Ghaffar, S.K.; Hussein, M.R. The biochemical and morphological alterations following administration of melatonin, retinoic acid and Nigella sativa in mammary carcinoma, an animal model. Int. J. Exp. Pathol., 2005, 86(6), 383-396 (Pubitemid 41746377)
139. Gonzalez, A.; Alvarez-Garcia, V.; Martinez-Campa, C.; Mediavilla, M.D.; Alonso-Gonzalez, C.; Sanchez-Barcelo, E. J.; Cos, S. In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin. Curr. Cancer Drug Targets, 2010, 10(3), 279-286
140. Vaskova, J.; Kassayova, M.; Vasko, L. Potential role of melatonin in DNA damage caused by nitrosourea-induced mammary carcinogenesis. Acta Histochem., 2011, 113(4), 423-427
141. Yang, Q.H.; Xu, J.N.; Xu, R.K.; Pang, S.F. Inhibitory effects of melatonin on the growth of pituitary prolactin-secreting tumor in rats. J. Pineal Res., 2006, 40(3), 230-235
142. Vesnushkin, G.M.; Plotnikova, N.A.; Semenchenko, A.V.; Anisimov, V.N. Melatonin inhibits urethane-induced carcinogenesis tumors in murine lung. Vopr. Onkol., 2006, 52(2), 164-168 (Pubitemid 43874467)
143. Perissin, L.; Zorzet, S.; Rapozzi, V.; Giraldi, T. Effects of different light cycles and stress on urinary excretion of melatonin and tumor spread in mice bearing Lewis lung carcinoma. Pharmacol. Res., 1989, 21Suppl 1, 131-132 (Pubitemid 20083447)
144. Ko, C.H.; Shen, S.C.; Yang, L.Y.; Lin, C.W.; Chen, Y.C. Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells. Int. J. Cancer, 2007, 121(8), 1670-1679
145. Gonzalez-Puga, C.; Garcia-Navarro, A.; Escames, G.; Leon, J.; Lopez-Cantarero, M.; Ros, E.; Acuña-Castroviejo, D. Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation, synergism with pharmacological levels of melatonin. J. Pineal Res., 2005, 39(3), 243-550
146. Wenzel, U.; Nickel, A.; Daniel, H. Melatonin potentiates flavone-induced apoptosis in human colon cancer cells by increasing the level of glycolytic end products. Int. J. Cancer, 2005, 116(2), 236-242 (Pubitemid 40967260)
147. Liu, H.; Xu, L.; Wei, J.E.; Xie, M.R.; Wang, S.E.; Zhou, R.X. Role of CD4+ CD25+ regulatory T cells in melatonin-mediated inhibition of murine gastric cancer cell growth in vivo and in vitro. Anat. Rec. (Hoboken), 2011, 294(5), 781-788
148. Um, H.J.; Park, J.W.; Kwon, TK. Melatonin sensitizes Caki renal cancer cells to kahweol-induced apoptosis through CHOP-mediated up-regulation of PUMA. J. Pineal Res., 2011, 50(4), 359-366
149. Um. H.J.; Kwon, T.K. Protective effect of melatonin on oxaliplatin-induced apoptosis through sustained Mcl-1 expression and anti-oxidant action in renal carcinoma Caki cells. J. Pineal Res., 2010, 49(3), 283-290
150. Han, Y.; Demorrow, S.; Invernizzi, P.; Jing, Q.; Glaser, S.; Renzi, A.; Meng, F.; Venter, J.; Bernuzzi, F.; White, M.; Francis, H.; Lleo, A.; Marzioni, M.; Onori, P.; Alvaro, D.; Torzilli, G.; Gaudio, E.; Alpini, G. Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma, its synthesis is reduced favoring cholangiocarcinoma growth. Am. J. Physiol. Gastrointest. Liver Physiol., 2011, 301(4), G623-G633
151. Leja-Szpak, A.; Jaworek, J.; Pierzchalski, P.; Reiter, R.J. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J. Pineal Res., 2010, 49(3), 248-255
152. Carbajo-Pescador, S.; Garcia-Palomo, A.; Martin-Renedo, J.; Piva, M.; Gonzalez-Gallego, J.; Mauriz, J.L. Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line, role of the MT1 receptor. J. Pineal Res., 2011, 51(4), 463-471
153. Fan, L.L.; Sun, G.P.; Wei, W.; Wang, Z.G.; Ge, L.; Fu, W.Z.; Wang, H. Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines. World J. Gastroenterol., 2010, 16(12), 1473-1481
154. Ozdemir, F.; Deniz, O.; Kaynar, K.; Arslan, M.; Kavgaci, H.; Yildiz, B.; Aydin, F. The effects of melatonin on human hepatoma (Hep G2) cell line. Bratisl. Lek. Listy, 2009, 110(5), 276-279
155. Martin-Renedo, J.; Mauriz, J.L.; Jorquera, F.; Ruiz-Andres, O.; Gonzalez, P.; Gonzalez-Gallego, J. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J. Pineal Res., 2008, 45(4), 532-540
156. She, M.H.; Chen, B.B.; Wang, X.M.; He, S.S. p53-dependent antiproliferation and apoptosis of H22 cell induced by melatonin. Ai Zheng, 2004, 23(7), 803-807
157. Qin, L.; Wang, X.; Duan, Q.; Chen, B.; He, S. Inhibitory effect of melatonin on the growth of H22 hepatocarcinoma cells by inducing apoptosis. J. Huazhong Univ. Sci. Technolog. Med. Sci., 2004, 24(1), 19-31
158. Gong, L.H.; Ren, D.H.; Xiong, M.; Lu, Z.Q.; Wang, X.M. Melatonin in vitro apoptosis of H22 hepatocarcinoma cells. Zhonghua Zhong Liu Za Zhi, 2003, 25(6), 550-554
159. Pandey, S.; Lopez, C.; Jammu, A. Oxidative stress and activation of proteasome protease during serum deprivation-induced apoptosis in rat hepatoma cells, inhibition of cell death by melatonin. Apoptosis., 2003, 8(5), 497-508 (Pubitemid 37247992)
160. Hermann, R.; Podhajsky, S.; Jungnickel, S.; Lerchl, A. Potentiation of antiproliferative effects of tamoxifen and ethanol on mouse hepatoma cells by melatonin, possible involvement of mitogen-activated protein kinase and induction of apoptosis. J. Pineal Res., 2002, 33(1), 8-13 (Pubitemid 34833069)
161. Radogna, F.; Nuccitelli, S.; Mengoni, F.; Ghibelli, L. Neuroprotection by melatonin on astrocytoma cell death. Ann. N. Y. Acad. Sci., 2009, 1171, 509-13.
162. Feng, Z.; Zhang, J.T. Protective effect of melatonin on beta-amyloid-induced apoptosis in rat astroglioma C6 cells and its mechanism. Free Radic. Biol. Med., 2004, 37(11), 1790-1801 (Pubitemid 39441063)
163. Martin, V.; Garcia-Santos, G.; Rodriguez-Blanco, J.; Casado-Zapico, S.; Sanchez-Sanchez, A, Antolin, I, Medina, M.; Rodriguez, C. Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death. Cancer Lett., 2010, 287(2), 216-223
164. Pizarro, J.G.; Yeste-Velasco, M.; Esparza, J.L.; Verdaguer, E.; Pallas, M.; Camins, A.; Folch, J. The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes. J. Pineal Res., 2008, 45(1), 8-16 (Pubitemid 351986256)
165. Suresh, C.; Dennis, A.O.; Heinz, J.; Vemuri, M.C.; Chetty, C.S. Melatonin protection against lead-induced changes in human neuroblastoma cell cultures. Int. J. Toxicol., 2006, 25(6), 459-464 (Pubitemid 44885101)
166. Garcia-Santos, G.; Antolin, I.; Herrera, F.; Martin, V.; Rodriguez-Blanco, J.; del Pilar Carrera, M.; Rodriguez, C. Melatonin induces apoptosis in human neuroblastoma cancer cells. J. Pineal Res., 2006, 41(2), 130-135 (Pubitemid 44141747)
167. Deng, Y.Q.; Xu, G.G.; Duan, P.; Zhang, Q.; Wang, J.Z. Effects of melatonin on wortmannin-induced tau hyperphosphorylation. Acta Pharmacol. Sin., 2005, 26(5), 519-526 (Pubitemid 40676159)
168. An, Y.; Liu, E.; Liu, X.; Yang, F.; Han, F.; Dai, Q. Protective effect of melatonin on neural cells against the cytotoxicity of oxyradicals. Chin. Med. Sci. J., 2000, 15(1), 40-44 (Pubitemid 30161102)
169. Benitez-King, G.; Tunez, I.; Bellon, A.; Ortiz, G.G.; Anton-Tay, F. Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in N1E-115 cells. Exp. Neurol., 2003, 182(1), 151-159 (Pubitemid 36776258)
170. Weinreb, O.; Mandel, S.; Youdim, M.B. cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells. FASEB J., 2003, 17(8), 935-937
171. Kolsch, H.; Ludwig, M.; Lutjohann, D.; Rao, M.L. Neurotoxicity of 24-hydroxycholesterol.; an important cholesterol elimination product of the brain may be prevented by vitamin E and estradiol-17beta. J. Neural Transm., 2001, 108(4), 475-488 (Pubitemid 32703896)
172. Hawkins, V.; Shen, Q.; Chiueh, C.C. Kynostatin and 17beta-estradiol prevent the apoptotic death of human neuroblastoma cells exposed to HIV-1 protease. J. Biomed. Sci., 1999, 6(6), 433-438 (Pubitemid 29505920)
173. Pappolla, M.A.; Sos, M.; Omar, R.A.; Bick, R.J.; Hickson-Bick, D.L.; Reiter, R.J.; Efthimiopoulos, S.; Robakis, N.K. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci., 1997, 17(5), 1683-1690 (Pubitemid 27089813)
174. Raza, H.; John, A.; Brown, E.M.; Benedict, S.; Kambal, A. Alterations in mitochondrial respiratory functions.; redox metabolism and apoptosis by oxidant 4-hydroxynonenal and antioxidants curcumin and melatonin in PC12 cells. Toxicol. Appl. Pharmacol., 2008, 226(2), 161-168
175. Ishido, M. Melatonin inhibits maneb-induced aggregation of alpha-synuclein in rat pheochromocytoma cells. J. Pineal Res., 2007, 42(2), 125-130 (Pubitemid 46233057)
176. Paternoster, L.; Radogna, F.; Accorsi, A.; Cristina Albertini, M.; Gualandi, G.; Ghibelli, L. Melatonin as a modulator of apoptosis in B-lymphoma cells. Ann. N. Y. Acad. Sci., 2009, 1171, 345-349
177. Buyukavci, M.; Ozdemir, O.; Buck, S.; Ravindranath, Y.; Savasan, S. Effect of melatonin on the cytotoxicity of chemotherapeutic drugs in human leukemia cells. In Vivo, 2011, 25(3), 405-409
178. Bejarano, I.; Espino, J.; Marchena, A.M.; Barriga, C.; Paredes, S.D.; Rodriguez, A.B.; Pariente, J.A. Melatonin enhances hydrogen peroxideinduced apoptosis in human promyelocytic leukaemia HL-60 cells. Mol. Cell. Biochem., 2011, 353(1-2), 167-176
179. Bejarano, I.; Espino, J.; Barriga, C.; Reiter, R.J.; Pariente, J.A.; Rodriguez, A.B. Pro-oxidant effect of melatonin in tumour leucocytes, relation with its cytotoxic and pro-apoptotic effects. Basic Clin. Pharmacol. Toxicol., 2011, 108(1), 14-20
180. Jang, S.S.; Kim, W.D.; Park, W.Y. Melatonin exerts differential actions on X-ray radiation-induced apoptosis in normal mice splenocytes and Jurkat leukemia cells. J. Pineal Res., 2009, 47(2), 147-155
181. Buyukavci, M.; Ozdemir, O.; Buck, S.; Stout, M.; Ravindranath, Y.; Savasan, S. Melatonin cytotoxicity in human leukemia cells, relation with its pro-oxidant effect. Fundam. Clin. Pharmacol., 2006, 20(1), 73-79
182. Trubiani, O.; Recchioni, R.; Moroni, F.; Pizzicannella, J.; Caputi, S.; Di Primio, R. Melatonin provokes cell death in human B-lymphoma cells by mitochondrial-dependent apoptotic pathway activation. J. Pineal Res., 2005, 39(4), 425-431
183. Majsterek, I.; Gloc, E.; Blasiak, J.; Reiter, R.J. A comparison of the action of amifostine and melatonin on DNA-damaging effects and apoptosis induced by idarubicin in normal and cancer cells. J. Pineal Res., 2005, 38(4), 254-263 (Pubitemid 41475437)
184. Petranka, J.; Baldwin, W.; Biermann, J.; Jayadev, S.; Barrett, J.C.; Murphy, E. The oncostatic action of melatonin in an ovarian carcinoma cell line. J. Pineal Res., 1999, 26(3), 129-136 (Pubitemid 29183115)
185. Pirozhok, I.; Meye, A.; Hakenberg, O.W.; Fuessel, S.; Wirth, M.P. Serotonin and melatonin do not play a prominent role in the growth of prostate cancer cell lines. Urol Int., 2010, 84(4), 452-460
186. Joo, S.S.; Yoo, Y.M. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways, therapeutic implications for prostate cancer. J. Pineal Res., 2009, 47(1), 8-14
187. Sainz, R.M.; Reiter, R.J.; Tan, D.X.; Roldan, F.; Natarajan, M.; Quiros, I.; Hevia, D.; Rodriguez, C.; Mayo, J.C. Critical role of glutathione in melatonin enhancement of tumor necrosis factor and ionizing radiation-induced apoptosis in prostate cancer cells in vitro. J. Pineal Res., 2008, 45(3), 258-270
188. Kim, J.H.; Jeong, S.J.; Kim, B.; Yun, S.M.; Choi, D.Y.; Kim, S.H. Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells. J. Pineal Res., 2012, 52(2), 244-252
189. Proietti, S.; Cucina, A.; D'Anselmi, F.; Dinicola, S.; Pasqualato, A.; Lisi, E.; Bizzarri, M. Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGFbeta-1-dependent growth inhibition of breast cancer cells. J. Pineal Res., 2011, 50(2), 150-158
190. Mao, L.; Cheng, Q.; Guardiola-Lemaitre, B.; Schuster-Klein, C.; Dong, C.; Lai, L.; Hill, S.M. In vitro and in vivo antitumor activity of melatonin receptor agonists. J. Pineal Res., 2010, 49(3), 210-221
191. Cucina, A.; Proietti, S.; D'Anselmi, F.; Coluccia, P.; Dinicola, S.; Frati, L.; Bizzarri, M. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells. J. Pineal Res., 2009, 46(2), 172-180
192. Korkmaz, A.; Tamura, H.; Manchester, L.C.; Ogden, G.B.; Tan, D.X.; Reiter, R.J. Combination of melatonin and a peroxisome proliferatoractivated receptor-gamma agonist induces apoptosis in a breast cancer cell line. J. Pineal Res, 2009, 46(1), 115-116
193. Jawed, S.; Kim, B.; Ottenhof, T.; Brown, G.M.; Werstiuk, E.S.; Niles, L.P. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation. Eur. J. Pharmacol., 2007, 560(1), 17-22
194. Czeczuga-Semeniuk, E.; Wolczynski, S.; Anchim, T.; Dzieciol, J.; Dabrowska, M.; Pietruczuk, M. Effect of melatonin and all-trans retinoic acid on the proliferation and induction of the apoptotic pathway in the culture of human breast cancer cell line MCF-7. Pol. J. Pathol., 2002, 53(2), 59-65
195. Cos, S.; Mediavilla, M.D.; Fernandez, R.; Gonzalez-Lamuno, D.; Sanchez-Barcelo, E.J. Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro? J. Pineal Res., 2002, 32(2), 90-96 (Pubitemid 34289586)
196. Eck-Enriquez, K.; Kiefer, T.L.; Spriggs, L.L.; Hill, S.M. Pathways through which a regimen of melatonin and retinoic acid induces apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res. Treat., 2000, 61(3), 229-239 (Pubitemid 30609556)
197. Eck, K.M.; Yuan, L.; Duffy, L.; Ram, P.T.; Ayettey, S.; Chen, I.; Cohn, C.S.; Reed, J.C.; Hill, S.M. A sequential treatment regimen with melatonin and alltrans retinoic acid induces apoptosis in MCF-7 tumour cells. Br. J. Cancer., 1998, 77(12), 2129-2137 (Pubitemid 28263932)
198. Cho, J.W.; Kim, C.W.; Lee, K.S. Modification of gene expression by melatonin in UVB-irradiated HaCaT keratinocyte cell lines using a cDNA microarray. Oncol. Rep., 2007, 17(3), 573-577
199. Chuang, J.I.; Chang, T.Y.; Liu, H.S. Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin. Oncogene., 2003, 22(9), 1349-1357 (Pubitemid 36384596)
200. Yang, Q.H.; Xu, J.N.; Xu, R.K.; Pang, S.F. Antiproliferative effects of melatonin on the growth of rat pituitary prolactin-secreting tumor cells in vitro. J. Pineal Res., 2007, 42(2), 172-179
201. El-Missiry, M.A.; Abd El-Aziz, A.F. Influence of melatonin on proliferation and antioxidant system in Ehrlich ascites carcinoma cells. Cancer Lett., 2000, 151(2), 119-125 (Pubitemid 30156785)
202. Casado-Zapico, S.; Rodriguez-Blanco, J.; Garcia-Santos, G.; Martin, V.; Sanchez-Sanchez, A.M.; Antolin, I.; Rodriguez, C. Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells, potentiation of the extrinsic apoptotic pathway. J. Pineal Res., 2010, 48(1), 72-80
203. Fic, M.; Podhorska-Okolow, M.; Dziegiel, P.; Gebarowska, E.; Wysocka, T.; Drag-Zalesinska, M.; Zabel, M. Effect of melatonin on cytotoxicity of doxorubicin toward selected cell lines (human keratinocytes lung cancer cell line A-549, laryngeal cancer cell line Hep-2). In Vivo., 2007, 21(3), 513-518 (Pubitemid 46901411)